Nathaniel Marchetti
Medical Director, Respiratory Intensive Care Unit, Temple University Hospital · Temple University Hospital
Credentials: · · · · ·
History
PresentRespiratory Intensive Care Unit · Temple University Hospital
- Present
- 2001–2003
Research
Azithromycin for prevention of exacerbations of COPD
New England Journal of Medicine · 2011 · 930 citations
Immunity · 2015 · 300 citations
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD
New England Journal of Medicine · 2014 · 284 citations
79 papers
17 papers
16 papers
16 papers
16 papers
- ES
14 papers
13 papers
13 papers
Grants
- 2022–2027
Impact of Quercetin on Inflammatory and Oxidative Stress Markers in COPD
National Center for Complementary and Integrative Health · R33
PI · $1.1M · Temple Univ of the Commonwealth
- 2018–2022
Impact of Quercetin on Inflammatory and Oxidative Stress Markers in COPD
National Center for Complementary and Integrative Health · R61
PI · $615.8K · Temple Univ of the Commonwealth
Clinical trials
- 2023–2025
Biological Effects of Quercetin in COPD Phase II
Principal investigator · Unknown · Phase 2
Temple University
- 2019–2025
Biological Effects of Quercetin in COPD
Principal investigator · Unknown · Phase 1, Phase 2
Temple University
- 2010–2031
Study of COPD Subgroups and Biomarkers
Principal investigator · Active not recruiting
University of North Carolina, Chapel Hill
- 2026–2031
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Site PI · Recruiting · Phase 2
Johns Hopkins University